Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novocure Stock Briefly Fell Today

TheMotleyFool

0 0

In response to the reported fourth-quarter and full-year results, shares of NovoCure (NASDAQ: NVCR), a high-growth medical device company that is focused on cancer, fell as much as 12% in early-morning trading on Thursday. The stock eventually recovered and was down about 2% as of 3:05 p.m. EST.

Investors got a sneak peek at the company's fourth-quarter results in mid-January, so Wall Street already had a good idea of what the company's numbers looked like.

Here are the rest of the details from the period:

Source Fool.com

Like: 0

NVCR

Share